LMAN2 and breast cancer: Single-cell analysis and drug resistance analyses combined with DNA damage repair analysis showed that LMAN2 might be involved in HR DNA damage repair, thereby affecting the chemotherapy resistance of HER2 subtype breast cancer, consequently affecting the prognosis.